Curia unveils comprehensive mRNA solution
| Date | 7th, Jan 2022 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today unveiled its messenger RNA solution, which includes discovery, process development and mRNA drug substance production, through large-scale lipid manufacturing, lipid nanoparticle formulation and development for full-scale sterile fill-finish services.